Tm Bioscience reports Genzyme Genetics launch of upgraded cystic fibrosis test
Advertisement
Tm Bioscience Corporation announced that Genzyme Genetics launched its upgraded CFplus(TM) cystic fibrosis (CF) mutation analysis which now includes testing for 97 mutations. Genzyme Genetics' new CFplus(TM) assay incorporates technology from Tm Bioscience which was developed in a collaborative effort.
Tm Bioscience's product menu is focused in the fields of human genetic disorders, pharmacogenetics and infectious disease. The Company has commercialized Analyte Specific Reagents and a series of Tag-It(TM) tests(xx) for a variety of genetic disorders. The Company's Tag-It(TM) Cystic Fibrosis Kit is the first multiplexed human disease genotyping test to be cleared by the U.S. Food and Drug Administration as an in vitro device for diagnostic use in the United States. All genetic tests from Tm Bioscience are based on the Tag-It(TM) Universal Array platform, which utilizes a proprietary universal tag system that allows for easy optimization, product development and expansion.
Other news from the department research and development
These products might interest you
